Role of BK(Ca) channels and cyclic nucleotides in synergistic relaxation of trachea

Eur J Pharmacol. 2000 Jun 30;399(1):75-84. doi: 10.1016/s0014-2999(00)00373-3.

Abstract

beta-Adrenoceptor agonists, nitric oxide (NO), and NO donors have been shown to mediate their effects through large conductance Ca(2+)-activated K(+) (BK(Ca)) channels. The mechanism of the synergistic effect of the beta(2)-adrenoceptor agonist, salbutamol, and an NO donor, sodium nitroprusside, was studied in guinea pig tracheal preparations. Salbutamol (0.1 nM) and sodium nitroprusside (0.33 microM) alone relaxed the acetyl-beta-methylcholine chloride (methacholine)-contracted preparations only by 0.5% and 28%, respectively, but their combination caused a maximum of 60% relaxation (at 3 min), which stabilized to 40% (at 10 min). Iberiotoxin, a selective inhibitor of the BK(Ca) channels, did not abolish the synergistic effect. 3-isobutyl-1-methylxanthine (IBMX) did not modify relaxation evoked by the drugs. Concentrations of cyclic nucleotides did not correlate with relaxations as a function of time. The mechanism of synergy remains to be clarified. The results show that NO is an important modulator in the relaxation of guinea pig trachea induced by beta(2)-adrenoceptor agonists in vitro.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • Albuterol / pharmacology
  • Animals
  • Calcium / pharmacology*
  • Cyclic AMP / analysis
  • Cyclic AMP / physiology*
  • Cyclic GMP / analysis
  • Cyclic GMP / physiology*
  • Dose-Response Relationship, Drug
  • Guinea Pigs
  • In Vitro Techniques
  • Male
  • Nitroprusside / pharmacology
  • Peptides / pharmacology
  • Phosphodiesterase Inhibitors / pharmacology
  • Potassium Channels / physiology*
  • Trachea / drug effects
  • Trachea / physiology*

Substances

  • Peptides
  • Phosphodiesterase Inhibitors
  • Potassium Channels
  • Nitroprusside
  • iberiotoxin
  • Cyclic AMP
  • Cyclic GMP
  • Albuterol
  • Calcium
  • 1-Methyl-3-isobutylxanthine